The 2024 Nobel Prize in Chemistry was recently granted to David Baker, Demis Hassabis and John M. Jumper, renowned for their pioneering works in protein design.

The success of pharmaceutical companies in developing drugs for treating and curing medical conditions is largely dependent on the quality and completeness of data they gather from clinical trials and ...

Tako has integrated QUODD's financial market data into its knowledge graph, enabling natural-language access to authoritative ...

TransUnion’s collaboration with Actable exemplifies the growing importance of data in the marketing landscape. By leveraging advanced analytics and AI, companies can refine their marketing strategies ...

Explore how intelligent document processing transforms dark, unstructured data into actionable intelligence—enabling faster ...

Aithon is an AI-native GTM platform built for regulated financial services. Aithon combines enterprise first-party systems with external market and regulatory signals, applying a financial-services ...

Custom Ink reports a shift in corporate swag from disposable items to quality merchandise, focusing on durability and ...

Pfizer Inc. Buy: market overreacts to Q4 loss and 2026 guidance; oncology-led growth, 102-candidate pipeline, and dividend ...

Raghab Singh’s research advances structure-first AI models for healthcare, combining molecular geometry and language ...

TradeOS supports 12,500+ assets today across Stocks, Forex, and Commodities -- and is already gaining strong traction with active trader communities in the U.S., Canada, Hong Kong, and Southeast Asia, ...

As well as behavioural and technical issues, firms must also solve a variety of organisational problems to make AI work for ...